Announcements and Notices - [Quarterly Results / Inside Information]

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. is a pharmaceutical company. Through its subsidiaries, the Company manufactures genetic medicines, Chinese traditional medicines, diagnostic products, and medical instruments, provides technology, marketing, and advertising services, as well as invests in import and export trading.

Shanghai Fosun Pharmaceutical (Group) (2196 HK)

2024 First Quarterly Report

Announcements and Notices - [Overseas Regulatory Announcement - Other]

Overseas Regulatory Announcement - Announcement In Relation To The Approval For Drug Registration Of A Subsidiary

Notification Letter And Request Form To Non-Registered Shareholders

Financial Statements/ESG Information - [Annual Report / Environmental, Social and Governance Information/Report]

Shanghai Fosun Pharmaceutical (Group) (2196 HK)

2024 First Quarterly Report

Overseas Regulatory Announcement - Announcement In Relation To The Approval For Drug Registration Of A Subsidiary

Notification Letter And Request Form To Non-Registered Shareholders

Annual Report 2023

Overseas Regulatory Announcement - Announcement In Relation To The Acceptance Of A Subsidiary'S Drug Registration Application